11 November 2026
Supporting Clinical Startups to Empower Innovation Throughout the NHS
Supporting Clinical Startups to Empower Innovation Throughout the NHS

Clinical insight can reveal a better way to care for patients. But insight alone won’t take an innovation from a promising idea to routine NHS use.
That takes a team. Alongside clinical expertise, you need business thinking, NHS relationships and the practical ability to manage change. Without that mix, even a strong innovation can stall between the pilot and wider adoption.
The NHS doesn’t lack innovation. It needs support to implement it.
The often-quoted “17-year gap” between research and practice traces back to Balas and Boren’s 2000 review. A 2025 critique points out that the studies behind it varied by specialty and measure, so it is a warning rather than a reliable countdown. The wider point still holds: developing evidence and changing everyday practice are different jobs.
The King’s Fund’s 2018 report on adoption and spread found that less than 0.1% of available NHS resources was set aside for adoption and spread — a historical estimate, but a telling one. It also found that taking an innovation to another site is rarely copy-and-paste: pathways, roles and processes change, and a pilot can lose effectiveness as it is replicated (“voltage drop”). The Health Foundation’s work on scaling makes the same case: spread depends on support for local teams to adapt and deliver.
In 2026, the King’s Fund put it plainly: the challenge is not a shortage of innovation, but turning it into lasting impact through delivery. (From Strategy to Delivery)
A strong sector. A demanding route to adoption.
The UK HealthTech startup sector is substantial. Startup Coalition’s HealthTech Index 2025 assessed 1,000 UK HealthTech startups: by end-2024 a combined valuation of £32 billion, £27.4 billion raised, almost 30,000 people employed, an average of £9.6 million raised per firm and 168 exits. Those figures describe the index companies, not NHS procurement — but they show the scale of the opportunity.
There is also proof of what coordinated support achieves. The NHS Innovation Accelerator’s ten-year impact report reports 140 evidence-based innovations reaching more than 10 million patients across 3,500 NHS sites, with fellows raising over £243 million (self-reported, first-decade figures). The NHS Clinical Entrepreneur Programme’s year-six statistics recorded 423 start-ups created and 12,804 instances of organisations adopting its innovations (based on 386 respondents).
These programmes show the value of connecting innovators to networks and support. They don’t remove the work of implementing a product in a particular service, with its own people, processes and priorities.
Clinical expertise needs a delivery team around it
Clinical founders understand the problem at first hand. They know what a pathway misses, where time is wasted and what could improve care. That knowledge is essential.
But NHS adoption also asks practical questions:
- Who needs to agree to a pilot, and who will pay for it?
- How does the innovation fit with current clinical workflows and digital systems?
- What evidence will a buyer need to make a decision?
- Who needs training, and what changes to roles or processes will follow?
- How will risks, information governance and patient safety be managed?
- What happens when a pilot ends?
Answering these questions is a team effort. A multidisciplinary team might include clinical leadership to build trust with peers, business and commercial expertise to set a viable offer, procurement and stakeholder support to navigate buying routes, transformation and project delivery to keep decisions moving, training support to prepare staff, and information governance input to handle data responsibly.
Not every startup needs all these skills full-time. But the work still needs to be done. When it falls to the founder alone, delivery competes with product development, clinical work and fundraising. A good idea may end up with a polished pilot and no clear next step.

Plan the path beyond the pilot
A pilot should test more than whether the product works. Before starting, agree the problem and intended benefit, the people and decisions involved, the changes required (training, workflows, integration), the evidence and measures, and the route afterwards: what success would mean, who makes the next decision and what wider adoption would need.
That last point matters. A successful pilot is evidence to support a decision. It is not, by itself, a decision to scale.
Practical delivery support without building a permanent team
Clinical startups often need experienced delivery capacity for a specific stage: planning a rollout, managing a pilot, coordinating NHS stakeholders or preparing for a wider implementation. Hiring a full-time team for a temporary need may not make sense.
SkyRocket provides implementation delivery and fractional project support for health tech businesses: hands-on delivery, client relationships through change, procurement and bid support, or cover when demand outgrows your team — agreed at a day rate, sized to the work.
We bring more than 25 years of UK healthcare programme delivery experience and a PRINCE2 Agile approach, supported by Capybara, our delivery platform for plans, actions, risks and reporting. Our implementation services give you experienced support without turning a temporary need into permanent headcount. Once the work is delivered, we step back.

Innovation reaches patients through people and delivery
Clinical founders bring vital insight. Business and transformation skills turn that insight into an NHS-ready change and a route beyond the pilot. You don’t need to build a large internal programme team — you need the right skills at the right time.
If you’re preparing a pilot or planning a rollout, talk to SkyRocket.
